Healthcare

According to a new market report published by Lucintel, the future of the global interventional cardiology and peripheral vascular device market looks promising with opportunities in hospitals and ambulatory surgical centers. The global interventional cardiology and peripheral vascular device market is expected to reach an estimated $28.5 billion by 2025, and it is forecast to grow at a CAGR of 6.1% from 2020 to 2025. The major drivers for the growth of this market include the growing elderly population, a rise in the prevalence of chronic diseases, advancements in medical technology and research, improvement of healthcare infrastructure in developing countries, and change in lifestyles and associated conditions leading to cardiovascular disorders. 

 

In this market, angioplasty balloons, angioplasty stents, angioplasty catheters, EAVR stent grafts, IVC filters, embolic protection devices, guidewires, arteriotomy closure devices, intravascular ultrasound systems, and synthetic surgical grafts are the segments by device type. On the basis of comprehensive research, Lucintel forecasts that the EVAR stent graft segment will show above average growth during the forecast period.

 

By end use, the global interventional cardiology and peripheral vascular device market is segmented into hospitals and ambulatory surgical centers. The hospital segment is expected to remain the largest segment in the forecast period as hospitals have a much higher budget than ambulatory surgical centers.

 

North America is expected to remain the largest market during the forecast period mainly due to its well-developed healthcare infrastructure and continued technological advancements across the healthcare industry. 

 

APAC is expected to witness the highest growth over the forecast period due to improving healthcare infrastructure in developing economies like China and India.

 

Emerging trends which have a direct impact on the dynamics of the market include rising adoption of TAVR procedures, increasing use of bioresorbable stents, and a rise in adoption of drug eluting balloons. Medtronic Plc, Boston Scientific, Abbott Laboratories, Terumo, and Becton, Dickinson and Company, are among the major suppliers of interventional cardiology and peripheral vascular devices.

 

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global interventional cardiology and peripheral vascular device market by type, device, end use, and region, and has compiled a comprehensive research report entitled “Growth Opportunities in the Global Interventional Cardiology and Peripheral Vascular Device Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy by providing comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global interventional cardiology and peripheral vascular device market by type, device, end use, and region, as follows:

 

By Type [Value ($ Million) from 2014 to 2025]:

By Device Type [Value ($ Million) from 2014 to 2025]: 

By End Use [Value ($ Million) for 2014 and 2025]:

By Region [Value ($ Million) from 2014 to 2025]:

This 192-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx or helpdesk@lucintel.com.

 

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.